Home Tools
Log in
Cart

Brivanib (alaninate)

Catalog No. T2576   CAS 649735-63-7
Synonyms: BMS-582664, Brivanib Alaninate

Brivanib Alaninate (BMS-582664) is the alaninate salt of a vascular endothelial growth factor receptor 2 (VEGFR2) inhibitor with potential antineoplastic activity. Brivanib strongly binds to and inhibits VEGFR2, a tyrosine kinase receptor expressed almost exclusively on vascular endothelial cells; inhibition of VEGFR2 may result in inhibition of tumor angiogenesis, inhibition of tumor cell growth, and tumor regression.

All products from TargetMol are for Research Use Only. Not for Human or Veterinary or Therapeutic Use.
Brivanib (alaninate) Chemical Structure
Brivanib (alaninate), CAS 649735-63-7
Pack Size Availability Price/USD Quantity
1 mg In stock $ 57.00
2 mg In stock $ 81.00
5 mg In stock $ 117.00
10 mg In stock $ 210.00
25 mg In stock $ 375.00
50 mg In stock $ 612.00
100 mg In stock $ 975.00
1 mL * 10 mM (in DMSO) In stock $ 138.00
Bulk Inquiry
Get quote
Select Batch  
Purity: 99.66%
Purity: 99.23%
Contact us for more batch information
Biological Description
Chemical Properties
Storage & Solubility Information
Description Brivanib Alaninate (BMS-582664) is the alaninate salt of a vascular endothelial growth factor receptor 2 (VEGFR2) inhibitor with potential antineoplastic activity. Brivanib strongly binds to and inhibits VEGFR2, a tyrosine kinase receptor expressed almost exclusively on vascular endothelial cells; inhibition of VEGFR2 may result in inhibition of tumor angiogenesis, inhibition of tumor cell growth, and tumor regression.
Targets&IC50 FLK1:89 nM, FGFR1:148 nM, VEGFR1:380 nM, VEGFR2:25 nM
In vitro In rats, administration of 25 mg/kg BMS-582664 resulted in an area under the curve (AUC) of 13.4 μM×hr and a peak concentration (Cmax) of 6.4 μM. In mice, 50 mg/kg BMS-582664 achieved an AUC of 136 μM×hr and a Cmax of 41 μM. At doses of 50 mg/kg and 100 mg/kg, BMS-582664 inhibited tumor growth rates by 55% and 13%, respectively, in mice bearing patient-derived xenograft tumor 06-0606. Oral administration of 60 mg/kg BMS-582664 significantly reduced tumor weight, promoted apoptosis, decreased microvascular density, inhibited cell proliferation, and downregulated cell cycle regulation in mice with patient-derived xenograft tumor 06-0606. Mice administered 60 mg/kg BMS-582664 orally displayed rapid absorption with a maximum concentration time (Tmax) of 1 hour, a half-life (t1/2) of 2.7 hours, and a mean residence time of 3.6 hours. The growth of H3396 xenograft tumors in athymic mice was dose-dependently inhibited by 60 mg/kg and 90 mg/kg BMS-582664, with tumor growth inhibition rates of 85% and 97%, respectively. Doses of 80 mg/kg and 107 mg/kg BMS-582664 dose-dependently inhibited tumor growth in athymic mice bearing L2987 non-small cell lung cancer xenograft tumors, with tumor growth inhibition rates of 85% and 97%, respectively. At a dose of 100 mg/kg, BMS-582664 inhibited the growth of endothelial cells in two mouse xenograft models (L2987 and HCT116).
In vivo BMS-582664 exhibits high solid stability, with only 0.3% degradation after a 12-cycle period at 50°C in the presence of desiccants and good liquid stability at pH 6.5. At 2 μM concentration, BMS-582664 significantly inhibits the phosphorylation of VEGFR-2, FGFR-1, ERK1/2, and Akt in SK-HEP1 and HepG-2 cells stimulated by VEGF and bFGF, without affecting the phosphorylation levels in unstimulated cells. It also inhibits the proliferation of HUVECs stimulated by VEGF and FGF, with IC50 values of 40 nM and 276 nM, respectively. Furthermore, BMS-582664 inhibits the enzymes CYP2C19, CYP3A4(BFC), and CYP3A4 (BzRes), with IC50 values of 2.4 μM, 0.51 μM, and 1.6 μM, respectively.
Kinase Assay Kinase inhibition assays: For the VEGFR2, Flk1 and FGFR1 kinase assays, BMS-582664 is dissolved in DMSO and diluted with water/10% DMSO to a final DMSO concentration of 2%. The kinase reactions consists of 8 ng of enzymes with GST tag, 75 μg/mL substrate, 1 μM ATP, and 0.04 μCi [γ-33P]ATP in 50 μL total reaction volume (kinase buffer:? 20 mM Tris, pH 7.0, 25 μg/mL BSA, 1.5 mM MnCl2, 0.5 mM dithiothreitol). In all cases, the reactions are incubated for 60 min at 27℃ and terminated with the addition of cold trichloroacetic acid (TCA) to a final concentration of 15%. The percent inhibition from the kinase assays is determined by nonlinear regression analyses, and data are reported as the inhibitory concentration required to achieve 50% inhibition relative to control reactions (IC50).
Cell Research Cells are grown in 100 μL of minimal growth medium and 1.0% heat-inactivated fetal bovine serum in 96-well collagen IV coated plates at a density of 2 × 103 per well in a 37 ℃/5% CO2 environment. Twenty-four hours later, serum is adjusted to 10%, and BMS-582664 at various dilutions are added to each well in a final volume of minimal growth media that contains 10% serum. Forty-eight hours later, 0.5 μCi of [3H]thymidine is added in a volume of 20 μL of minimal media for 24 hours. Plates are washed once in PBS. Upon removal of PBS, Trypsin is added to cells which are subsequently harvested onto glass-fiber filters using an automated harvestor. Incorporated tritium is quantified using a β-counter. Dose?response curves are generated to determine the IC50 value, which is defined as the concentration of drug required to inhibit 50% of tritium incorporation when compared to untreated serum-stimulated cells.(Only for Reference)
Synonyms BMS-582664, Brivanib Alaninate
Molecular Weight 441.46
Formula C22H24FN5O4
CAS No. 649735-63-7

Storage

Powder: -20°C for 3 years | In solvent: -80°C for 1 year

Solubility Information

Ethanol: 82 mg/mL (185.7 mM)

DMSO: 82 mg/mL (185.7 mM)

TargetMolReferences and Literature

1. Bhide RS, et al. J Med Chem, 2006, 49(7), 2143-2146. 2. Huynh H, et al. Clin Cancer Res, 2008, 14(19), 6146-6153. 3. Cai ZW, et al. J Med Chem, 2008 , 51(6), 1976-1980. 4. Ayers M, et al. Cancer Res, 2007, 67(14), 6899-6906.

Related compound libraries

This product is contained In the following compound libraries:
Tyrosine Kinase Inhibitor Library Kinase Inhibitor Library Anti-Cancer Drug Library Anti-Cancer Active Compound Library Drug Repurposing Compound Library Inhibitor Library Anti-Cancer Clinical Compound Library Clinical Compound Library Bioactive Compounds Library Max Autophagy Compound Library

Related Products

Related compounds with same targets
5Z-7-Oxozeaenol AZD4547 Conbercept Sorafenib-d3 Ribociclib WHI-P180 Oglufanide hCA/VEGFR-2-IN-2

TargetMolDose Conversion

You can also refer to dose conversion for different animals. More

TargetMol In vivo Formulation Calculator (Clear solution)

Step One: Enter information below
Dosage
mg/kg
Average weight of animals
g
Dosing volume per animal
ul
Number of animals
Step Two: Enter the in vivo formulation
% DMSO
%
% Tween 80
% ddH2O
Calculate Reset

TargetMolCalculator

Molarity Calculator
Dilution Calculator
Reconstitution Calculation
Molecular Weight Calculator
=
X
X

Molarity Calculator allows you to calculate the

  • Mass of a compound required to prepare a solution of known volume and concentration
  • Volume of solution required to dissolve a compound of known mass to a desired concentration
  • Concentration of a solution resulting from a known mass of compound in a specific volume
See Example

An example of a molarity calculation using the molarity calculator
What is the mass of compound required to make a 10 mM stock solution in 10 ml of water given that the molecular weight of the compound is 197.13 g/mol?
Enter 197.13 into the Molecular Weight (MW) box
Enter 10 into the Concentration box and select the correct unit (millimolar)
Enter 10 into the Volume box and select the correct unit (milliliter)
Press calculate
The answer of 19.713 mg appears in the Mass box

X
=
X

Calculator the dilution required to prepare a stock solution

Calculate the dilution required to prepare a stock solution
The dilution calculator is a useful tool which allows you to calculate how to dilute a stock solution of known concentration. Enter C1, C2 & V2 to calculate V1.

See Example

An example of a dilution calculation using the Tocris dilution calculator
What volume of a given 10 mM stock solution is required to make 20ml of a 50 μM solution?
Using the equation C1V1 = C2V2, where C1=10 mM, C2=50 μM, V2=20 ml and V1 is the unknown:
Enter 10 into the Concentration (start) box and select the correct unit (millimolar)
Enter 50 into the Concentration (final) box and select the correct unit (micromolar)
Enter 20 into the Volume (final) box and select the correct unit (milliliter)
Press calculate
The answer of 100 microliter (0.1 ml) appears in the Volume (start) box

=
/

Calculate the volume of solvent required to reconstitute your vial.

The reconstitution calculator allows you to quickly calculate the volume of a reagent to reconstitute your vial.
Simply enter the mass of reagent and the target concentration and the calculator will determine the rest.

g/mol

Enter the chemical formula of a compound to calculate its molar mass and elemental composition

Tip: Chemical formula is case sensitive: C10H16N2O2 c10h16n2o2

Instructions to calculate molar mass (molecular weight) of a chemical compound:
To calculate molar mass of a chemical compound, please enter its chemical formula and click 'Calculate'.
Definitions of molecular mass, molecular weight, molar mass and molar weight:
Molecular mass (molecular weight) is the mass of one molecule of a substance and is expressed n the unified atomic mass units (u). (1 u is equal to 1/12 the mass of one atom of carbon-12)
Molar mass (molar weight) is the mass of one mole of a substance and is expressed in g/mol.

bottom

Tech Support

Please see Inhibitor Handling Instructions for more frequently ask questions. Topics include: how to prepare stock solutions, how to store products, and cautions on cell-based assays & animal experiments, etc.

Keywords

Brivanib (alaninate) 649735-63-7 Angiogenesis Autophagy Tyrosine Kinase/Adaptors FGFR VEGFR BMS 582664 Inhibitor Vascular endothelial growth factor receptor BMS582664 BMS-582664 alaninate Brivanib inhibit Brivanib Alaninate inhibitor

 

TargetMol